Hemophilia A is an X chromosome-linked disorder resulting from deficiency of factor VIII, an important protein in blood coagulation. A large number of diseaseproducing mutations have been reported in the factor VIII gene. However, a comprehensive analysis of the mutations has been difficult because of the large gene size, its many scattered exons, and the high frequency of de novo mutations. Recently, we have shown that nearly all mutations resulting in mild-tomoderate hemophilia A can be detected by PCR and denaturing gradient gel electrophoresis (DGGE). In this study, we attempted to discover the mutations causing severe hemophilia A by analyzing 47 unselected patients, 30 of whom had severe hemophilia and 17 of whom had mild-to-moderate disease. Using DGGE as a screening method, we analyzed 99% of the coding region, 94% of the splice junctions, the promoter region, and the polyadenylylation site ofthe gene. We found the mutation in 16 of 17 (94%) patients with mild-to-moderate disease but in only 16 of 30 (53%) patients with severe hemophilla A. Since DGGE after computer analysis appears to detect all mutations in a given fagment, the lower-thanexpected yield of mutations in patients with severe disease is likely not due to failure of the detection method; it is probably due to the presence of mutations in DNA sequences outside the regions studied. Such sequences may include locus-controlling regions, other sequences within introns or outside the gene that are important for its expression, or another gene involved in factor VIII expression that is very closely linked to the factor VIII gene.
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Hemophilia A is a common hereditary disorder of blood coagulation resulting from deficiency of factor VIII. Factor VIII is a plasma glycoprotein that after posttranslational modification plays an important role in the intrinsic coagulation pathway (1, 2) . Patients with hemophilia A are classified according to clinical severity and the activity of factor VIII in their plasma. In severe, moderate, and mild hemophilia A, factor VIII activity is <1%, 1-5%, and 5-30%o, respectively. The factor VIII gene has been cloned (3, 4) and mapped to the distal long arm of the X chromosome (5) . A large number of mutations in the factor VIII gene that cause hemophilia A have been reported (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The factor VIII gene is 186 kilobases and contains 26 exons. It is difficult to characterize all possible mutations in patients both because of the large size of the gene and because different mutations exist in unrelated patients due to the high frequency of de novo mutations.
A number of screening methods have been developed to detect point mutations, including direct genomic sequencing (10, 16) , chemical (17) or enzymatic cleavage (18, 19) of nucleotide mismatches, discriminant oligonucleotide hybridization (7, 14) , denaturing gradient gel electrophoresis (DGGE) (11, 12, (19) (20) (21) , and single-strand gel electrophoresis (SSGE) (22) . All of these methods are used after PCR amplification.
Recently, we have used DGGE analysis to detect all possible mutations in 29 patients with mild-to-moderate hemophilia A. DGGE analysis was an excellent method since the disease-producing mutation was found in 25 of these patients (15) .
In this report, we used a similar analysis in 47 unselected patients with hemophilia A, 30 of whom had severe disease. Our goal was to compare the nature of mutations in severe hemophiliacs with those in patients with mild-to-moderate disease. The disease-producing mutation was found in nearly all patients with mild-to-moderate hemophilia A (16 of 17); however, the mutation was found in only 16 of 30 patients with severe disease.
MATERIALS AND METHODS Subjects. We studied 47 unselected patients with hemophilia A whose mutations in the factor VIII gene were unknown. Of these patients, 30 had severe hemophilia A and 17 had mild-to-moderate disease. All the patients with severe disease have factor VIII activity of <1%, while mild-tomoderate patients have factor VIII activity ranging from 2% to 29%. Two of the 30 patients with severe hemophilia A developed antibodies against factor VIII after transfusion therapy.
Southern Blot Analysis. Restriction endonuclease analysis was performed as described elsewhere (23) using Taq I and three subfragments of factor VIII cDNA as hybridization probes (4, 23) .
Amplification of Genomic DNA. Amplification of high molecular weight genomic DNA from leukocytes was performed by PCR (15, 24) . The entire coding region, 47 of 50 splice junctions, promoter region including the TATA box, and 150 nucleotides 5' to the cap site and 345 nucleotides from the 3' untranslated and flanking region including the polyadenylylation site offactor VIII gene were amplified by using 47 pairs of oligonucleotide primers. A 40-nucleotide (nt) G+C-rich sequence (G+C clamp) was attached to either the 5' or the 3' primer (15, 25) . Computer analysis was carried out by using the programs MELT87 and SQHTX provided by L. Lerman (Massachusetts Institute of Technology, Cambridge) to aid the choice of PCR primers (15, 26) . Forty-five sets of primers were described elsewhere (15) ; the two additional sets used here were (i) 5'-(GC)x-GCTCCTGTTCACTTTGACTT-3' and 5'-AGAGCTCTA1TTGCATGACTTA-3' for the promoter region containing the probable TATA box and the 5' mRNA start site (3) and (iU) 5'-ATAGCCCGGTAGAG-GAGTTAAC-3' and 5'-(GC)x-CATTTCTGATTTATTT-TATTCAGAC-3' for the polyadenylylation site. (GC)x indicates a 40-nt G+C clamp (15) . Amplification was performed with 200-400 ng of genomic DNA template, 400 nM each primer, 200 uM each dNTP and 2 units of Taq polymerase per 100-01 reaction mixture for 35 cycles (at 940C for 20 sec, thermal transition from 94TC to the annealing temperature over 2 min, 520C-550C for 45 sec, and 720C for 30-60 sec).
DGGE and Sequence Analysis. DGGE was performed under conditions determined empirically for a given PCR product as described (19, 21) . Approximately 80 ng of PCR product from each of two patients was combined to form heteroduplexes. Electrophoresis was performed on a 6.5% polyacrylamide gel (14 cm x 19 cm x 0.75 mm) containing a linear gradient ofdenaturants at 2-5 V/cm for 16-23 hr. DNA fragments were visualized after staining with ethidium bromide. PCR products showing abnormal migrating patterns were directly sequenced (15, 16) .
DNA Po1ynophisn Anaysis. Amplification ofgenomic DNA and subsequent restriction analysis of PCR products were performed as described (15, 27) . Factor VIII haplotypes were derived for six polymorphic sites in the factor VIII gene: intervening sequence 7 (IVS7), nt 27 (11, 12); exon 14, codon 1421 (3, 15) ; exon 14, codon 1488 (15); IVS18, Bc! I site (27) ; IVS22, Xba I site (28); a G to A nucleotide substitution, 110 nt 5' to the polyadenylylation site, first found as a nucleotide difference between cloned cDNA and genomic DNA (3). The frequency of the latter site was determined by DGGE. Haplotypes at the remaining sites were determined as described (15, 27) .
RESULTS
We used two different methods to screen for mutations in 47 patients with hemophilia A. First, DGGE analysis of amplified products was carried out to detect nucleotide substitutions and insertion-deletion of a few nucleotides (6) . An example of DGGE screening for mutations is shown in Fig.  1 . Second, we used Southern blot analysis to identify gross factor VIII gene rearrangements. Table 1 (15) . As predicted from the computer analysis, mutations that occur within the 5' two-thirds of exon 7 and IVS6 were not detected when the exon 7 fragment was analyzed, because these mutations do not reside within the first melting domain of the exon 7 fragment. However, these mutations were distinguishable from normal when the exon 7A fragment was analyzed because they are located within the first melting domain of the latter fragment. amplification by PCR; furthermore, the two large deletions and two nucleotide substitutions that alter Taq I sites were also detected by Southern blot analysis. In addition, a rare Taq I site DNA polymorphism either in IVS4 or in IVS6 was identified in three patients (JH-82, JH-83, JH-84). The remaining 29 patients listed in Table 1 had only one mutation in the DNA regions studied.
Our analysis included 47 regions of the factor VIII gene containing 99% ofthe coding region, 47 of50 splicejunctions, the promoter region and the polyadenylylation site region. The mutation was not identified in 15 patients-14 of 30 (47%) patients with severe hemophilia A and 1 of 17 (6%) patients with mild-to-moderate disease.
Among 25 single nucleotide substitutions, 23 were missense and 2 were nonsense mutations. Three different mutations were found in more than 1 patient (see Table 1 ) and, therefore, the total number of distinct molecular lesions was 27. Six of these 27 defects have been described (see Table 1 for references). A considerable number of mutations occur in CG dinucleotides conforming to the CG to TG "mutation hot spot" rule. These included 14 of 32 (44%) total mutations or 14 of 25 (56%) single nucleotide substitutions. (Table 2) .
We selected DGGE as a screening method because we had concluded that DGGE after computer analysis could detect nearly all point mutations. Previously, we were able to identify mutations in 25 of the 29 patients with mild-tomoderate hemophilia A (15) ( Table 2 ). Moreover, in that study 26 other known point mutations in the factor VIII gene were analyzed, and all were distinguishable from normal by this method (15) .
In the present study, mutation detection in patients with mild-to-moderate hemophilia A was, as expected, nearly complete; however, detection of mutations in severe disease was only 53%. In contrast, in severe hemophilia B due to factor IX deficiency, the causative mutation was detected in the coding region of the factor IX gene in 17 of 17 patients analyzed (33) . Four explanations of the low yield of mutations in severe hemophilia A may be entertained.
(i) DGGE analysis is not an optimal method to detect deletions or insertions of a few nucleotides. However, this is unlikely because three known frameshift mutations including deletions of 2 and 3 nt and insertion of 1 nt were detected by DGGE. Furthermore, in this study we identified four frameshift mutations due to insertion of 1 nt in three cases and deletion of 2 nt in one case. The number of frameshift mutations identified in this study [4 3 -globin gene that produce P-thalassemia are internal intron mutations, and only 2 of these produce (3-thalassemia (35) . No known mutations in the 3' untranslated region of genes produce severe phenotypes. All 12 known point mutations in the promoter region of the 3globin gene produce f+-thalassemia (35) . On the other hand, a rare de novo deletion of the locus-activating region of the f-globin gene cluster completely inhibits the expression of the /-globin gene (36 (15) . In this study, we identified aTyr-473 to His substitution, indicating that this amino acid residue is of functional importance. Genetics: Higuchi et aL
The Ala-704 to Thr mutation due to a G to A change at a CpG dinucleotide was found in two unrelated patients (JH-78 and JH-79) with two different factor VIII haplotypes. The mutation in JH-78 occurred de novo in his mother; therefore, this suggests that the Ala-704 to Thr substitution in the A2 domain is the disease-producing mutation in this patient, although the amino acid substitution does not seem to be dramatic.
JH-81 with severe hemophilia A had an insertion of an A residue within eight consecutive A residues in exon 14. Usually~, this type of mutation is due to slippage in replication (39) . Interestingly, in another group ofhemophilia A patients, we found one case with deletion of an A residue within the same stretch of eight A residues (15) . Both mutations were detected by DGGE.
The coding region of the factor VIII gene contains 70 CpG dinucleotides. In this study, we identified 9 different CpG hot spot mutations, of which 5 were not previously described. All told, a total of 25 of 70 CpG dinucleotides have been found to be altered by disease-producing mutations (refs. 6-8, 14, and 15; this work).
Complete characterization of mutations in a specific genetic disease may provide information about unsuspected and/or unrecognized regulatory elements of the gene responsible for the disease or may reveal the existence of an unknown gene(s) that also causes the phenotype of the specific disorder.
